Abstract:Liver cancer is one of the leading causes of death motivating scientists worldwide to synthesize novel therapeutics. Ru(II)-polypyridyl complexes are extensively studied for possible therapeutic and cellular applications due to their tunable coordination chemistry, structural diversity, ligand-exchange kinetics, accessible redox states, and rich photophysical or photochemical properties. Herein, we have synthesized a series of Ru(II) polypyridyl complexes [RuII(N^N) 2 (ox)] ( 1 - 3 ), where ox is oxalate (C2O42-), N^N is 1,10-phenanthroline (phen) ( 1 ), dipyrido[3,2-d:2',3'-f]quinoxaline (dpq) ( 2 ), and dipyrido[3,2,-a:2',3'-c]phenazine (dppz) ( 3 ). The oxalate (ox 2- ) was opted as a bioactive dioxo ligand to prevent hydrolysis in aqueous media, thereby increasing the stability of the Ru(II)-polypyridyl complexes in physiological media. We thoroughly characterized all the complexes using ESI-MS, FT-IR, UV-vis, and 1H NMR spectroscopy and other physicochemical methods. The complexes were stable under physiological conditions and under low-energy green LED light (λirr= 530 nm). However, the photoirradiation of complexes resulted in the efficient generation of singlet oxygen ( 1 O 2 ) as a major reactive oxygen species (ROS). The role of extended aromatic conjugation of the N^N-donor ligands in the complexes was demonstrated on their binding propensities with CT-DNA and bovine serum albumin (BSA). Both DNA intercalation and groove binding are evidenced, while tryptophan (Trp) and tyrosine (Tyr) binding preferences are revealed from the synchronous fluorescence spectral (SFS) of BSA. The cytotoxic profiling of the complexes performed on hepatocellular carcinoma cells (HepG2) in the dark and in the presence of green light indicated their dose-dependent cytotoxicity. The [Ru II (N^N)2(ox)] complexes exhibit enhanced photocytotoxicity mediated by efficient generation of cytotoxic 1 O 2 and DNA interaction. All the complexes internalize to the HepG2 liver cancer cells efficiently and localize to the cytoplasm and nucleus. The complexes exhibited potent anti-proliferative, anti-clonogenic, and anti-migratory effects on the cancer cells, suggesting their potential promise for therapeutic applications.

Photoinduced synergistic cytotoxicity towards cancer cells <i>via</i> Ru(II) complexes

Photodynamic antitumor activity of Ru(ii) complexes of imidazo-phenanthroline conjugated hydroxybenzoic acid as tumor targeting photosensitizers.

Novel Tris-bipyridine Based Ru(II) Complexes as Type-I/-II Photosensitizers for Antitumor Photodynamic Therapy Through Ferroptosis and Immunogenic Cell Death

The cell-impermeable Ru(II) polypyridyl complex as a potent intracellular photosensitizer under visible light irradiation via ion-pairing with suitable lipophilic counter-anions

Increasing the cytotoxicity of Ru(II) polypyridyl complexes by tuning the electron donating ability of 1,10-phenanthroline ligands

Novel Ru(II) complexes with multiple anticancer photoreactivity: ligand exchange, photoredox catalysis, reactive oxygen generation and endoperoxide formation

Donor–Acceptor–Donor Strategy Rouses the Photodynamic Therapy Anticancer Activity of a Bis-terpyridyl Ru(II) Complex

Ruthenium(II) Polypyridyl Complexes As Mitochondria-Targeted Two-Photon Photodynamic Anticancer Agents

Synthesis, characterization and biological evaluation of mixed-ligand ruthenium(II) complexes for photodynamic therapy

Biotin-conjugated Ru(II) complexes with AIE characteristics as mitochondria-targeted photosensitizers for enhancing photodynamic therapy by disrupting cellular redox balance

Converting an Almost Noncytotoxic Ru(II) Complex with Photolabile Ligands into a Highly Efficient PACT Agent

A 700 Nm LED Light Activated Ru(II) Complex Destroys Tumor Cytoskeleton Via Photosensitization and Photocatalysis

Photochemical property of a Ru(II) compound based on 3-(2-pyridyl)pyrazole and 2,2′-bipyridine for ablation of cancer cells

Photocytotoxic Kinetically Stable Ruthenium(II)-N,N-donor Polypyridyl Complexes of Oxalate for Anticancer Activity Against HepG2 Liver Cancer Cells

Mixed-ligand ruthenium polypyridyl complexes as apoptosis inducers in cancer cells, the cellular translocation and the important role of ROS-mediated signaling.

Ruthenium Complex-Modified Carbon Nanodots For Lysosome-Targeted One- And Two-Photon Imaging And Photodynamic Therapy

Ru(ii) polypyridyl complex-incorporated and folate-conjugated vehicle for cancer cell imaging and photoinduced inactivation.

Insights into the anticancer photodynamic activity of Ir(III) and Ru(II) polypyridyl complexes bearing β-carboline ligands

Photoresponsive ruthenium-containing polymers: potential polymeric metallodrugs for anticancer phototherapy.

Design of a Tris-Heteroleptic Ru(II) Complex with Red-Light Excitation and Remarkably Improved Photobiological Activity

A lysosome-targeted ruthenium(II) polypyridyl complex as photodynamic anticancer agent